{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:50:27Z","timestamp":1789732227365,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA21765"],"award-info":[{"award-number":["CA21765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00467-025-06765-7","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T02:21:54Z","timestamp":1745374914000},"page":"2907-2917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of GFR estimation equations using creatinine, cystatin C, and their combination in pediatric hematology\u2013oncology: no single equation is superior across subgroups"],"prefix":"10.1007","volume":"40","author":[{"given":"Katelyn J.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane J.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Pauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro R.","family":"Molinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Bissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1546-9720","authenticated-orcid":false,"given":"Clinton F.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"6765_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00467-016-3373-x","volume":"32","author":"H Pottel","year":"2017","unstructured":"Pottel H (2017) Measuring and estimating glomerular filtration rate in children. Pediatr Nephrol 32:249\u2013263","journal-title":"Pediatr Nephrol"},{"key":"6765_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"6765_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00467-020-04770-6","volume":"36","author":"JL Holness","year":"2021","unstructured":"Holness JL, Brink A, Davids MR, Warwick JM (2021) Estimated glomerular filtration rate in children: adapting existing equations for a specific population. Pediatr Nephrol 36:669\u2013683","journal-title":"Pediatr Nephrol"},{"key":"6765_CR4","doi-asserted-by":"publisher","first-page":"e22413","DOI":"10.1002\/jcla.22413","volume":"32","author":"S Conkar","year":"2018","unstructured":"Conkar S, Mir S, Karaslan FN, Hakverdi G (2018) Comparing different estimated glomerular filtration rate equations in assessing glomerular function in children based on creatinine and cystatin C. J Clin Lab Anal 32:e22413","journal-title":"J Clin Lab Anal"},{"key":"6765_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/ajkd.2000.8237","volume":"36","author":"E Coll","year":"2000","unstructured":"Coll E, Botey A, Alvarez L, Poch E, Quint\u00f3 L, Saurina A, Vera M, Piera C, Darnell A (2000) Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36:29\u201334","journal-title":"Am J Kidney Dis"},{"key":"6765_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/pbc.20581","volume":"46","author":"P Lankisch","year":"2006","unstructured":"Lankisch P, Wessalowski R, Maisonneuve P, Haghgu M, Hermsen D, Kramm CM (2006) Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age. Pediatr Blood Cancer 46:767\u2013772","journal-title":"Pediatr Blood Cancer"},{"key":"6765_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/08880010390203099","volume":"20","author":"JR Brandt","year":"2003","unstructured":"Brandt JR, Wong C, Jones DR, Qualls C, McAfee N, Brewer E, Watkins SL (2003) Glomerular filtration rate in children with solid tumors: normative values and a new method for estimation. Pediatr Hematol Oncol 20:309\u2013318","journal-title":"Pediatr Hematol Oncol"},{"key":"6765_CR8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00467-017-3693-5","volume":"32","author":"VE Millisor","year":"2017","unstructured":"Millisor VE, Roberts JK, Sun Y, Tang L, Daryani VM, Gregornik D, Cross SJ, Ward D, Pauley JL, Molinelli A, Brennan RC, Stewart CF (2017) Derivation of new equations to estimate glomerular filtration rate in pediatric oncology patients. Pediatr Nephrol 32:1575\u20131584","journal-title":"Pediatr Nephrol"},{"key":"6765_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/sj.bjc.6601484","volume":"90","author":"M Cole","year":"2004","unstructured":"Cole M, Price L, Parry A, Keir MJ, Pearson AD, Boddy AV, Veal GJ (2004) Estimation of glomerular filtration rate in paediatric cancer patients using 51CR-EDTA population pharmacokinetics. Br J Cancer 90:60\u201364","journal-title":"Br J Cancer"},{"key":"6765_CR10","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1111\/jcpt.13235","volume":"45","author":"H Tsushita","year":"2020","unstructured":"Tsushita H, Tanaka R, Suzuki Y, Sato Y, Itoh H (2020) Effects of dose and type of corticosteroids on the divergence between estimated glomerular filtration rates derived from cystatin C and creatinine. J Clin Pharm Ther 45:1390\u20131397","journal-title":"J Clin Pharm Ther"},{"key":"6765_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1710-1492-9-30","volume":"9","author":"D Liu","year":"2013","unstructured":"Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H (2013) A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 9:30","journal-title":"Allergy Asthma Clin Immunol"},{"key":"6765_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/j.1875-9114.1993.tb02685.x","volume":"13","author":"JH Rodman","year":"1993","unstructured":"Rodman JH, Maneval DC, Magill HL, Sunderland M (1993) Measurement of Tc-99m DTPA serum clearance for estimating glomerular filtration rate in children with cancer. Pharmacotherapy 13:10\u201316","journal-title":"Pharmacotherapy"},{"key":"6765_CR13","unstructured":"D'Argenio DZ, Schumitzky A (1990) ADAPT II user\u2019s guide. Biomedical Simulations Resource, USC, Los Angeles"},{"key":"6765_CR14","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.kint.2020.10.047","volume":"99","author":"CB Pierce","year":"2021","unstructured":"Pierce CB, Mu\u00f1oz A, Ng DK, Warady BA, Furth SL, Schwartz GJ (2021) Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int 99:948\u2013956","journal-title":"Kidney Int"},{"key":"6765_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00280-023-04597-6","volume":"93","author":"M Lambert","year":"2024","unstructured":"Lambert M, Alonso M, Munzer C, Zimoch MC, Malard L, Gambart M, Castex MP, Martins C, Pasquet M, Chatelut E (2024) Prospective validation of an equation based on plasma cystatin C for monitoring the glomerular filtration rate in children treated with cisplatin or ifosfamide for cancer. Cancer Chemother Pharmacol 93:393\u2013395","journal-title":"Cancer Chemother Pharmacol"},{"key":"6765_CR16","doi-asserted-by":"publisher","first-page":"e28747","DOI":"10.1002\/pbc.28747","volume":"68","author":"M Lambert","year":"2021","unstructured":"Lambert M, White-Koning M, Alonso M, Garnier A, Alphonsa G, Puiseux C, Munzer C, Berthier J, Malard L, Pasquet M, Chatelut E (2021) Plasma cystatin C is a marker of renal glomerular injury in children treated with cisplatin or ifosfamide. Pediatr Blood Cancer 68:e28747","journal-title":"Pediatr Blood Cancer"},{"key":"6765_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ki.2012.169","volume":"82","author":"GJ Schwartz","year":"2012","unstructured":"Schwartz GJ, Schneider MF, Maier PS, Moxey-Mims M, Dharnidharka VR, Warady BA, Furth SL, Mu\u00f1oz A (2012) Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int 82:445\u2013453","journal-title":"Kidney Int"},{"key":"6765_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1200\/JCO.1993.11.3.554","volume":"11","author":"NM Marina","year":"1993","unstructured":"Marina NM, Rodman JH, Shema SJ, Bowman LC, Douglass E, Furman W, Santana VM, Hudson M, Wilimas J, Meyer W, Madden T, Pratt CB (1993) Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors. J Clin Oncol 11:554\u2013560","journal-title":"J Clin Oncol"},{"key":"6765_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/clpt.1993.163","volume":"54","author":"DJ Murry","year":"1993","unstructured":"Murry DJ, Sandlund JT, Stricklin LM, Rodman JH (1993) Pharmacokinetics and acute renal effects of continuously infused carboplatin. Clin Pharmacol Ther 54:374\u2013380","journal-title":"Clin Pharmacol Ther"},{"key":"6765_CR20","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/annonc\/mdu129","volume":"25","author":"R Cathomas","year":"2014","unstructured":"Cathomas R, Klingbiel D, Geldart TR, Mead GM, Ellis S, Wheater M, Simmonds P, Nagaraj N, von Moos R, Fehr M (2014) Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort. Ann Oncol 25:1591\u20131597","journal-title":"Ann Oncol"},{"key":"6765_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137\u2013147","journal-title":"Ann Intern Med"},{"key":"6765_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J (1992) A power primer. Psychol Bull 112:155\u2013159","journal-title":"Psychol Bull"},{"key":"6765_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ekir.2020.11.028","volume":"6","author":"SW Benoit","year":"2021","unstructured":"Benoit SW, Kathman T, Patel J, Stegman M, Cobb C, Hoehn J, Devarajan P, Nehus EJ (2021) GFR estimation after cystatin C reference material change. Kidney Int Rep 6:429\u2013436","journal-title":"Kidney Int Rep"},{"key":"6765_CR24","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/pbc.26043","volume":"63","author":"AJ Dodgshun","year":"2016","unstructured":"Dodgshun AJ, Quinlan C, Sullivan MJ (2016) Cystatin C based equation accurately estimates glomerular filtration rate in children with solid and central nervous system tumours: enough evidence to change practice? Pediatr Blood Cancer 63:1535\u20131538","journal-title":"Pediatr Blood Cancer"},{"key":"6765_CR25","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/jalm\/jfac043","volume":"7","author":"I Poventud-Fuentes","year":"2022","unstructured":"Poventud-Fuentes I, Garnett E, Akcan-Arikan A, Devaraj S (2022) Comparison of cystatin C and creatinine-based equations with measured glomerular filtration rate in a diverse pediatric population. J Appl Lab Med 7:1016\u20131024","journal-title":"J Appl Lab Med"},{"key":"6765_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/pbc.25194","volume":"62","author":"MB Bernhardt","year":"2015","unstructured":"Bernhardt MB, Moffett BS, Johnson M, Tam VH, Thompson P, Garey KW (2015) Agreement among measurements and estimations of glomerular filtration in children with cancer. Pediatr Blood Cancer 62:80\u201384","journal-title":"Pediatr Blood Cancer"},{"key":"6765_CR27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/pbc.23119","volume":"57","author":"HN Blufpand","year":"2011","unstructured":"Blufpand HN, Tromp J, Abbink FC, Stoffel-Wagner B, Bouman AA, Schouten-van Meeteren AY, van Wijk JA, Kaspers GJ, B\u00f6kenkamp A (2011) Cystatin C more accurately detects mildly impaired renal function than creatinine in children receiving treatment for malignancy. Pediatr Blood Cancer 57:262\u2013267","journal-title":"Pediatr Blood Cancer"},{"key":"6765_CR28","doi-asserted-by":"publisher","first-page":"e13977","DOI":"10.1111\/apha.13977","volume":"238","author":"SE Claudel","year":"2023","unstructured":"Claudel SE, Gandhi M, Patel AB, Verma A (2023) Estimating kidney function in patients with cancer: a narrative review. Acta Physiol (Oxf) 238:e13977","journal-title":"Acta Physiol (Oxf)"},{"key":"6765_CR29","first-page":"17960","volume":"269","author":"PJ Bosma","year":"1994","unstructured":"Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RP, Chowdhury JR, Chowdhury NR, Jansen PL (1994) Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J BiolChem 269:17960\u201317964","journal-title":"J BiolChem"},{"key":"6765_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2152\/jmi.65.231","volume":"65","author":"N Nakamura","year":"2018","unstructured":"Nakamura N, Watanabe H, Okamura K, Kagami S (2018) Assessment of renal function in Japanese children with malignancies using serum cystatin C. J Med Invest 65:231\u2013235","journal-title":"J Med Invest"},{"key":"6765_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.7754\/Clin.Lab.2015.150701","volume":"62","author":"JL Zhai","year":"2016","unstructured":"Zhai JL, Ge N, Zhen Y, Zhao Q, Liu C (2016) Corticosteroids significantly increase serum cystatin C concentration without affecting renal function in symptomatic heart failure. Clin Lab 62:203\u2013207","journal-title":"Clin Lab"},{"key":"6765_CR32","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/clinchem\/45.10.1866","volume":"45","author":"A B\u00f6kenkamp","year":"1999","unstructured":"B\u00f6kenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J (1999) Cystatin C serum concentrations underestimate glomerular filtration rate in renal transplant recipients. Clin Chem 45:1866\u20131868","journal-title":"Clin Chem"},{"key":"6765_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/pharmacy8010035","volume":"8","author":"HR Teaford","year":"2020","unstructured":"Teaford HR, Barreto JN, Vollmer KJ, Rule AD, Barreto EF (2020) Cystatin C: a primer for pharmacists. Pharmacy (Basel) 8:35","journal-title":"Pharmacy (Basel)"},{"key":"6765_CR34","first-page":"4271","volume":"59","author":"T Yoshinari","year":"1999","unstructured":"Yoshinari T, Ohkubo M, Fukasawa K, Egashira S, Hara Y, Matsumoto M, Nakai K, Arakawa H, Morishima H, Nishimura S (1999) Mode of action of a new indolocarbazole anticancer agent, J-107088, targeting topoisomerase I. Cancer Res 59:4271\u20134275","journal-title":"Cancer Res"},{"key":"6765_CR35","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","volume":"65","author":"EL Knight","year":"2004","unstructured":"Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE (2004) Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65:1416\u20131421","journal-title":"Kidney Int"},{"key":"6765_CR36","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ki.2008.638","volume":"75","author":"LA Stevens","year":"2009","unstructured":"Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS (2009) Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75:652\u2013660","journal-title":"Kidney Int"},{"key":"6765_CR37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/bcpt.13156","volume":"124","author":"E Iversen","year":"2019","unstructured":"Iversen E, Bodilsen AC, Klausen HH, Treldal C, Andersen O, Houlind MB, Petersen J (2019) Kidney function estimates using cystatin C versus creatinine: Impact on medication prescribing in acutely hospitalized elderly patients. Basic Clin Pharmacol Toxicol 124:466\u2013478","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"6765_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2215\/CJN.11721018","volume":"14","author":"MA Casal","year":"2019","unstructured":"Casal MA, Nolin TD, Beumer JH (2019) Estimation of kidney function in oncology: implications for anticancer drug selection and dosing. Clin J Am Soc Nephrol 14:587\u2013595","journal-title":"Clin J Am Soc Nephrol"},{"key":"6765_CR39","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","volume":"17","author":"AH Calvert","year":"1989","unstructured":"Calvert AH, Newell DR, Gumbrell LA (1989) Prospective evaluation of a simple formula based on renal function. J Clin Oncol 17:1748\u20131756","journal-title":"J Clin Oncol"},{"key":"6765_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1634\/theoncologist.3-1-15","volume":"3","author":"DS Alberts","year":"1998","unstructured":"Alberts DS, Dorr RT (1998) New perspectives on an old friend: optimizing carboplatin for the treatment of solid tumors. Oncologist 3:15\u201334","journal-title":"Oncologist"},{"key":"6765_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jso.2930530210","volume":"53","author":"Y Matsumoto","year":"1993","unstructured":"Matsumoto Y, Fujiwara T, Honjo Y, Sasaoka N, Tsuchida T, Nagao S (1993) Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11. J Surg Oncol 53:97\u2013103","journal-title":"J Surg Oncol"},{"key":"6765_CR42","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1200\/JCO.1993.11.12.2314","volume":"11","author":"DR Newell","year":"1993","unstructured":"Newell DR, Pearson AD, Balmanno K, Price L, Wyllie RA, Keir M, Calvert AH, Lewis IJ, Pinkerton CR, Stevens MC (1993) Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children\u2019s Cancer Study Group. J Clin Oncol 11:2314\u20132323","journal-title":"J Clin Oncol"},{"key":"6765_CR43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/bjc.1990.272","volume":"62","author":"CR Pinkerton","year":"1990","unstructured":"Pinkerton CR, Broadbent V, Horwich A, Levitt J, McElwain TJ, Meller ST, Mott M, Oakhill A, Pritchard J (1990) \u2019JEB\u2019\u2014a carboplatin based regimen for malignant germ cell tumours in children. Br J Cancer 62:257\u2013262","journal-title":"Br J Cancer"},{"key":"6765_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/(SICI)1096-911X(199804)30:4<217::AID-MPO3>3.0.CO;2-J","volume":"30","author":"JR Mann","year":"1998","unstructured":"Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Phillips M, Sokal M, Gray E, McKeever P, Oakhill A (1998) UKCCSG\u2019s germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours\u2013carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom Children\u2019s Cancer Study Group. Med Pediatr Oncol 30:217\u2013227","journal-title":"Med Pediatr Oncol"},{"key":"6765_CR45","doi-asserted-by":"publisher","first-page":"e27672","DOI":"10.1002\/pbc.27672","volume":"66","author":"PC Adamson","year":"2019","unstructured":"Adamson PC, Veal GJ, Womer RB, Meany HJ, Bernhardt MB, Frazier AL, Balis FM (2019) Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal function. Pediatr Blood Cancer 66:e27672","journal-title":"Pediatr Blood Cancer"},{"key":"6765_CR46","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.3390\/cancers13235963","volume":"13","author":"ME van de Velde","year":"2021","unstructured":"van de Velde ME, den Bakker E, Blufpand HN, Kaspers GL, Abbink FCH, Kors AWA, Wilhelm AJ, Honeywell RJ, Peters GJ, Stoffel-Wagner B, Buffart LM, B\u00f6kenkamp A (2021) Carboplatin dosing in children using estimated glomerular filtration rate: equation matters. Cancers (Basel) 13:5963","journal-title":"Cancers (Basel)"},{"key":"6765_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1523-1755.2000.00806.x","volume":"57","author":"PT Pham","year":"2000","unstructured":"Pham PT, Pham PC, Wilkinson AH, Lew SQ (2000) Renal abnormalities in sickle cell disease. Kidney Int 57:1\u20138","journal-title":"Kidney Int"},{"key":"6765_CR48","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3324\/haematol.2019.242156","volume":"106","author":"JD Lebensburger","year":"2021","unstructured":"Lebensburger JD, Gossett J, Zahr R, Wang WC, Ataga KI, Estepp JH, Kang G, Hankins JS (2021) High bias and low precision for estimated versus measured glomerular filtration rate in pediatric sickle cell anemia. Haematologica 106:295\u2013298","journal-title":"Haematologica"},{"key":"6765_CR49","doi-asserted-by":"publisher","first-page":"sfae006","DOI":"10.1093\/ckj\/sfae006","volume":"17","author":"T Vermassen","year":"2024","unstructured":"Vermassen T, Geboes K, Lumen N, Van Praet C, Rottey S, Delanghe J (2024) Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients. Clin Kidney J 17:sfae006","journal-title":"Clin Kidney J"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06765-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06765-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06765-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:30:59Z","timestamp":1757169059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06765-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6765"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06765-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}